Actively Recruiting
EKO SENSORA: Detecting Clinically Significant Murmurs
Led by Corewell Health South · Updated on 2025-12-12
300
Participants Needed
1
Research Sites
143 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Eko Artificial Intelligence (AI) has primarily been evaluated in the primary care setting. The digital stethoscope records a phonocardiogram of heart sounds of the patient and uses machine learning artificial intelligence to identify if there are abnormalities present (Eko Health, 2023). The Eko SENSORA will be tested in the emergency department. Chest pain, fatigue, shortness of breath and syncope are all symptoms that could indicate a cardiac dysfunction. The hypothesis is that this device will allow us increased ability to detect valvular heart disease that is clinically significant.
CONDITIONS
Official Title
EKO SENSORA: Detecting Clinically Significant Murmurs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Chief complaint of chest pain, shortness of breath, difficulty breathing, or syncope/near-syncope
- Patients with chief complaint of weakness who are over 50 years old and have at least two of the following: hypertension, BMI ≥ 30, diabetes, hyperlipidemia, atrial fibrillation, heart attack, stroke/transient ischemic attack, prior cardiac surgery or angiography
- Age 18 years or older
You will not qualify if you...
- Patients under contact isolation
- Patients younger than 18 years old
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Corewell Health Lakeland
Saint Joseph, Michigan, United States, 49085
Actively Recruiting
Research Team
M
Monique Luna, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here